AstraZeneca PLC (NASDAQ:AZN) Q1 2025 Earnings Call Transcript

AstraZeneca PLC (NASDAQ:AZN) Q1 2025 Earnings Call Transcript April 29, 2025

AstraZeneca PLC beats earnings expectations. Reported EPS is $1.3, expectations were $1.1.

Andy Barnett – Head of IR:

Pascal Soriot – Executive Director and CEO:

A pharmacy worker distributing prescription medicines to patientsreceiving treatment for oncology, cardiovascular, renal, metabolism and respiratory diseases.

Aradhana Sarin – Executive Director and CFO:

Dave Fredrickson – EVP, Oncology Business Unit:

Susan Galbraith – EVP, Oncology R&D:

Q&A Session

Follow Astrazeneca Plc (NYSE:AZN)